Research Papers

25 of 546 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Severity of functional tricuspid regurgitation is associated with mortality in patients with pulmonary hypertension in …
Yang Y; Chen H; Dong Q; Liao K; Huang W.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of l-citrulline on nitric oxide signaling and arginase activity in hypoxic human pulmonary artery endothelial ce…
Douglass MS; Kaplowitz MR; Zhang Y; Fike CD.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictors of hospitalization for respiratory failure among patients with sarcoidosis-associated pulmonary hypertension.
Gayen S; Mamary AJ.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Beneficial effects of berberine against pulmonary complications of experimental pulmonary arterial hypertension in rats…
Beik A; Najafipour H; Joukar S; Rajabi S; Masoumi-Ardakani Y; Dabiri S; Ziasistani M.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting <i>SELPLG/</i>P-selectin glycoprotein ligand 1 in preclinical ARDS: Genetic and epigenetic regulation of the …
Sun X; Sammani S; Hufford M; Sun BL; Kempf CL; Camp SM; Garcia JGN; Bime C.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Utility of cardiac magnetic resonance feature tracking strain assessment in chronic thromboembolic pulmonary hypertensi…
Leong K; Howard L; Giudice FL; Davies R; Haji G; Gibbs S; Gopalan D.
Pulm Circ (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension.
van der Have O; Mead TJ; Westöö C; Peruzzi N; Mutgan AC; Norvik C; Bech M; Struglics A; Hoetzenecker K; Brunnström H; Westergren-Thorsson G; Kwapiszewska G; Apte SS; Tran-Lundmark K.
Pulm Circ (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Metallomics in pulmonary arterial hypertension patients.
El-Kersh K; Hopkins CD; Wu X; Rai SN; Cave MC; Smith MR; Go YM; Jones DP; Cai L; Huang J.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Noninvasive determinants of pulmonary hypertension in interstitial lung disease.
Joseph P; Savarimuthu S; Zhao J; Yan X; Oakland HT; Cullinan M; Heerdt PM; Singh I.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The diagnostic and prognostic value of growth differentiation factor-15 in systemic lupus erythematosus-associated pulm…
Qian J; Ding Y; Yang X; Wang Q; Zhao J; Liu Y; Tian Z; Wang Y; Li M; Zeng X.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oral Liushen pill for patients with COVID-19: A prospective randomized controlled trial.
Zhang J; Liu Y; Lei W; Shen J; Lu J; Tao T; Cao X; Yang Z; Huang J; Shi C.
Pulm Circ (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Uncovering common pathobiological processes between COVID-19 and pulmonary arterial hypertension by integrating Omics d…
Wang RS; Loscalzo J.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pressure-based beat-to-beat right ventricular ejection fraction and Tau from continuous measured ventricular pressures …
Gaertner M; Glocker R; Glocker F; Hopf HB.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registries.
Runheim H; Kjellström B; Beaudet A; Ivarsson B; Husberg M; Pillai N; Levin LÅ; Bernfort L.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare…
Didden EM; Lee E; Wyckmans J; Quinn D; Perchenet L.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Second International Pulmonary Hypertension/Heart Failure Symposium-Structural heart disease, right ventricular dysfunc…
Chouvarine P; Hysko K; Chan SY; Oliveira P; Maron BA; Kourembanas S; Hansmann G.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bleomycin-induced lung injury: Revisiting an old tool to model group III PH associated with pulmonary fibrosis.
Santos-Ribeiro D; Lecocq M; de Beukelaer M; Bouzin C; Palmai-Pallag M; Yakoub Y; Huaux F; Horman S; Perros F; Pilette C; Godinas L.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hype…
Kumar S; Memon D; Raj M; Sen AC; Jayasankar JP; Leeladharan SP; Sudhakar A; Kumar RK.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from th…
Nathan SD; Fernandes P; Psotka M; Vitulo P; Piccari L; Antoniou K; Nikkho SM; Stockbridge N.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Nutritional status in pulmonary arterial hypertension.
Kwant CT; van der Horst FAL; Bogaard HJ; de Man FS; Vonk Noordegraaf A.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension.
Gillmeyer KR; Rinne ST; Qian SX; Maron BA; Johnson SW; Klings ES; Wiener RS.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension.
Zhang V; Ganz T; Nemeth E; Umar S; Kim A.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Long-term prognostic value of cardiac catheterization and acute vasodilator testing with inhaled iloprost in pediatric …
Zhang C; Dimopoulos K; Li Q; Gu H.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous …
Dodson MW; Cirulis MM; Elliott CG.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.
Colglazier E; Stevens L; Parker C; Nawaytou HM; Amin EK; Becerra J; Steurer M; Fineman JR.
Pulm Circ (Unknown)
Published: 2022
3/6 Transparent
Funding Declared